Immunology of SARS-CoV-2 vaccine responses and extended dosing intervals

Summary: The goal is to discuss mechanistic immunological evidence supporting the effect of vaccine dosing interval and pre-existing endemic coronavirus cross-reactivity on SARS-CoV-2 mRNA vaccine antibody responses. Presenter: Dr. Pascal Lavoie is clinician-scientist and immunology researcher at BC Children's Hospital and UBC, who leads the Tracking COVID-19 for Safer Schools study, and a COVID-19 Immunity Task Force-funded study looking at SARS-CoV-2 vaccine responses in healthcare workers and children at BC Children's and Women's and Surrey Memorial Hospitals.

BC CDC Presenters

1/18/2022 8:00:00 PM